Konstantin Konstantinov - Insider Trading & Ownership

Location
C/O Codiak Biosciences, Inc., 500 Technology Square, 9 Th Floor, Cambridge, MA
Summary
The estimated net worth of Konstantin Konstantinov is at least $404K dollars as of May 19, 2025. Konstantin Konstantinov is the Director of REPLIGEN CORP and owns shares of REPLIGEN CORP (RGEN) stock worth about $404K.
Signature
/s/ Marc Baumgartner (Attorney in Fact)
All Insider Reports
All Insider Reports

Ownership of Konstantin Konstantinov

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RGEN REPLIGEN CORP Director $404K May 15, 2025
CDAKQ Codiak BioSciences, Inc. Chief Technology Officer Mar 28, 2023

Insider Transactions Reported by Konstantin Konstantinov:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.